Daily Roundup

XRF Scientific Delivers Impressive Q2 Growth Across the Board

XRF Scientific Ltd is riding high after a stellar September quarter, with revenue jumping 38% to $21.1 million and profit before tax climbing 30% to $4.4 million. The company's diversified product lineup all contributed to the momentum—consumable sales hit $5.6 million while capital equipment brought in $5.9 million. The standout performer was Orbis, which saw revenue surge 66% to $2.4 million, while precious metals products also gained traction at $9.6 million. Perhaps most encouraging is that the company's new India office has already turned profitable, signaling successful international expansion. The integration of the CGA acquisition continues on track, with production expected to kick off in December. Management is bullish heading into the final quarter, anticipating strong contributions from new CGA instruments and continued Orbis momentum.

Baby Bunting Refurbishment Strategy Paying Off

Baby Bunting Group Ltd is proving that sometimes a fresh coat of paint goes a long way. The retailer reported record FY26 sales of $556 million, up 6.5%, with a healthy gross margin of 41.2%. The real story, though, is the company's store refurbishment program—17 locations have been refreshed, and those stores are delivering an impressive average sales lift of 20%. Comparable store sales growth came in at 3.5% for the full year. The company has also made some leadership changes, with Gary Levin retiring and Richard Vincent joining the board. Looking ahead to FY27, Baby Bunting is maintaining its guidance with pro forma net profit after tax expected between $19 million and $21 million, assuming total sales of $585 million to $600 million and comparable store sales growth of 3% to 5%. The company expects a gross margin of 42% and plans capital expenditure of $33 million to $37 million.

PainChek Accelerates US Expansion with Sabra Deal

PainChek Limited is making serious headway in the US market, expanding its footprint from two initial memory care facilities to 23 communities across five operators under its Master Services Agreement with Sabra Health Care REIT. The company is zeroing in on assisted living and memory care—a market representing an estimated 1.2 million potential license opportunities. With 808 memory care licenses now in its sights, PainChek's immediate priority is converting these contracts into implemented annual recurring revenue by the end of 2026. The company is also actively pursuing additional adoption opportunities throughout Sabra's broader portfolio and building relationships with other US assisted living and memory care operators.

Memphasys Accelerates International Growth

Memphasys Ltd is firing on all cylinders internationally, posting record invoiced revenues of $211,000 for the quarter—a 41% jump from the previous period. The company has been busy expanding its European distribution network with new agreements in Poland, the Nordic markets, and Central Asia. Meanwhile, regulatory approvals have opened doors in Vietnam, Thailand, and Turkey, where the company already has orders and distributor support lined up. Repeat orders from Italy, the UK, and the Middle East and North Africa region demonstrate solid demand from existing partners. The company also bolstered its commercial muscle by hiring Dr. Arne Schierau as Director of Commercial Operations Europe. On the funding front, Memphasys secured a $3.5 million agreement with Peters Investments to fuel commercial expansion, manufacturing capacity, and inventory growth. The company is also exploring a potential FDA 510(k) pathway for its Felix product, with pre-submission discussions planned to clarify US regulatory requirements.

Raiz Invest Tackles Historical Tax Compliance Issues

Raiz Invest Limited has identified historical tax compliance issues that require attention. The company discovered problems related to tax file number and Australian Business Number withholding and reporting obligations for certain funds offered through its platform since 2015. An independent review led by WTS Australia is underway to get to the bottom of the matter. Raiz has proactively notified both the Australian Taxation Office and the Australian Securities and Investments Commission and is cooperating fully with regulators. The company has launched a board-directed remediation program and promises to provide updates as the review progresses. The good news for customers: their funds remain secure, and no immediate action is required on their part.